Norroy Bioscience Co., Ltd
Clinical trials sponsored by Norroy Bioscience Co., Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a single injection reveal hidden kidney cancer? Results expected Mar 2027 (estimated)
- New scan could spot hidden prostate cancer spread Results expected Jun 2027 (estimated)
-
Can a radioactive injection extend life in advanced prostate cancer?
Disease control Not yet recruitingThis phase III trial tests whether adding a radioactive drug called 177Lu-NYM032 to standard care helps men with a specific type of advanced prostate cancer live longer. The drug targets a protein called PSMA found on many prostate cancer cells, delivering radiation directly to t…
Phase 3 • Sponsor: Norroy Bioscience Co., LTD • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a single injection reveal hidden kidney cancer?
Diagnosis Not yet recruitingThis early-stage trial tests an experimental imaging agent called 68Ga-NYM096 in 20 adults who have a kidney mass of uncertain nature seen on CT or MRI and are scheduled for surgery. The agent is designed to attach to a protein common on clear cell renal cell carcinoma cells, pot…
Phase 1 • Sponsor: Norroy Bioscience Co., LTD • Aim: Diagnosis
Last updated Aug 19, 2026 00:00 UTC